Abstract
A phase I trial of intrathecal Spartaject Busulfan (SuperGen, Inc., San Ramon, CA) was conducted in children with neoplastic meningitis following recurrent primary brain tumors to describe toxicities, estimate the maximum tolerated dose (MTD), and document evidence of responses to this agent. The continuous reassessment method was used to assign cohorts of patients to doses of intrathecal Spartaject Busulfan via an Ommaya reservoir and/or lumbar puncture twice weekly for 2 weeks followed by an assessment of toxicity and response. Patients with stable disease or an objective response continued to receive intrathecal Spartaject Busulfan plus systemic chemotherapy at regular intervals. Cerebrospinal fluid and blood were obtained for pharmacokinetic studies in patients with Ommaya reservoirs after the first dose of intrathecal Spartaject Busulfan. Seven evaluable patients were assigned to the starting dose of 5 mg, two patients to 7.5 mg, three patients to 10 mg, seven patients to 13 mg, and four patients to 17 mg. Between September 2000 and May 2003, 28 patients were enrolled in this study. Twenty-three patients (median age, 8.8 years; range, 2.5-19.5 years) were evaluable for estimating the MTD, and dose-limiting toxicities were ...Continue Reading
References
Aug 1, 1985·Annals of Neurology·R J PackerL Schut
Jun 15, 1995·Statistics in Medicine·S N GoodmanS Piantadosi
Jan 1, 1994·Cancer Chemotherapy and Pharmacology·R H AaronH S Friedman
Jan 1, 1997·Journal of Child Neurology·M C Chamberlain
Mar 10, 1999·British Journal of Cancer·I BolandA Gouyette
Mar 17, 2000·Journal of Neuro-oncology·G E ArcherH S Friedman
Nov 9, 2000·Leukemia·E OlavarriaJ Goldman
Aug 22, 2002·Bone Marrow Transplantation·J S McCuneJ T Slattery
Apr 12, 2003·Neuroimaging Clinics of North America·Sridharan Gururangan, Henry S Friedman
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shakeel ModakJonathan L Finlay
May 29, 2004·Anti-cancer Drugs·Celeste LindleyJoseph Wiley
Oct 2, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L BomgaarsS M Blaney
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan M BlaneyRichard Heideman
Citations
Oct 27, 2009·Cancer Chemotherapy and Pharmacology·Sharon ConroyDavid Walker
Jun 5, 2012·Cancer Chemotherapy and Pharmacology·Michael P GabayJ Lee Villano
Jun 2, 2009·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·M SangraC Mallucci
Mar 23, 2011·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Toshihisa TsurutaYoshikazu Okada
Jun 21, 2007·Current Treatment Options in Neurology·Jan Drappatz, Tracy T Batchelor
Jul 21, 2009·Anti-cancer Drugs·Martin BeneschChristian Urban
Oct 2, 2007·Current Opinion in Oncology·Jacques Grill, Ranjeev Bhangoo
Jul 29, 2011·The Oncologist·Giuseppe LombardiVittorina Zagonel
Jun 6, 2015·Artificial Cells, Nanomedicine, and Biotechnology·Marc Fakhoury
Nov 27, 2010·Neurosurgery Clinics of North America·Morris D Groves
Jul 24, 2007·The Lancet Oncology·Sophie WilneDavid Walker
May 7, 2010·Clinical and Translational Science·Arzu OnarJames M Boyett
Feb 13, 2010·Cancer·Michael J GlantzMarc C Chamberlain
Aug 19, 2015·Journal of Korean Neurosurgical Society·Ho-Shin GwakSeung Hoon Lee
May 5, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Nolwenn BrandhonneurPascal Le Corre
Jul 2, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexia Iasonos, John O'Quigley
Jul 6, 2010·The Lancet Oncology·Patrick Beauchesne
May 30, 2013·Surgical Neurology International·Emilie Le RhunMarc C Chamberlain
Jun 16, 2019·Cancers·Silvia TriaricoAntonio Ruggiero
Sep 23, 2010·Journal of Neuro-oncology·Sonia PartapPaul G Fisher
Sep 30, 2008·Journal of Neuro-oncology·Marc C ChamberlainMichael J Glantz
Jan 21, 2020·The Lancet Child & Adolescent Health·David A WalkerChristina Halsey